Please login to the form below

Not currently logged in
Email:
Password:

hypertriglyceridaemia

This page shows the latest hypertriglyceridaemia news and features for those working in and with pharma, biotech and healthcare.

FDA approves AZ’s fish oil drug

FDA approves AZ’s fish oil drug

The FDA approval covers its use as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridaemia. ... According to AZ, nearly four million adults in the US currently have severe hypertriglyceridaemia.

Latest news

  • FDA to review AZ's fish oil drug Epanova FDA to review AZ's fish oil drug Epanova

    The US Food and Drug Administration (FDA) will assess Epanova for use in the treatment of patients with severe hypertriglyceridaemia – an excess of fatty molecules called triglycerides in the blood. ... By tackling triglycerides, these oils can have

  • FDA gives priority review status to BMS/ AZ's metreleptin FDA gives priority review status to BMS/ AZ's metreleptin

    Amylin filed for approval of metreleptin in 2010 as a treatment for diabetes and/or hypertriglyceridaemia in LD patients, using a rolling biologics license application (BLA) that allowed the various parts

  • Amylin and Takeda halt obesity drug study

    In late 2010, Amylin began submission of a rolling US Biologics Licensing Application for metreleptin as monotherapy to treat diabetes and/or hypertriglyceridaemia (high levels of triglycerides in the bloodstream) in

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics